Financials
- Market Capitalization 31.66 M
- Employee 2
- Founded 2014
- CEO N/A
- Website www.enterothera.com
- Headquarter Delaware, United States
- FIGI BBG00DBBJ4T4
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.12
売上高対価格比率
207.82
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4340 | QNCX Quince Therapeutics, Inc. - Common Stock | 31.73 USD | 0.00% | +15.80% | +8.37% | +1494.47% | 32.27 M USD | ||
| 4342 | ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.02 USD | -3.77% | -6.42% | -28.17% | -1.92% | 32.07 M USD | ||
| 4359 | CVM Cel-Sci Corporation Common Stock | 1.76 USD | -5.88% | -37.14% | +18.92% | -65.83% | 30.96 M USD | ||
| 4377 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.71 USD | +4.91% | -1.72% | +3.64% | -82.02% | 28.95 M USD |